# Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas

> **NCT05952310** · NA · RECRUITING · sponsor: **Antonio Pérez Martínez** · enrollment: 10 (estimated)

## Conditions studied

- Malignant Sarcoma

## Interventions

- **OTHER:** Natural Killer (NK) cells (a new immunotherapy)

## Key facts

- **NCT ID:** NCT05952310
- **Lead sponsor:** Antonio Pérez Martínez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-24
- **Primary completion:** 2029-10-24
- **Final completion:** 2029-10-24
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05952310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05952310, "Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05952310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*